Clinical Trials Directory

Trials / Completed

CompletedNCT05560529

Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms.

Detailed description

Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms, with patients being randomly allocated in both groups.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDBTApplying DBT modules in group format over 20 weeks
DRUGTAUGiving TAU (usual pharmacotherapy in BED) over 20 weeks
DIAGNOSTIC_TESTPlasma GhrelinMeasuring fasting plasma ghrelin pre and post treatment in both arms

Timeline

Start date
2023-03-15
Primary completion
2024-06-15
Completion
2024-09-15
First posted
2022-09-29
Last updated
2025-01-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05560529. Inclusion in this directory is not an endorsement.